These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28004475)

  • 61. Novel shikonin derivatives targeting tubulin as anticancer agents.
    Guo J; Chen XF; Liu J; Lin HY; Han HW; Liu HC; Huang SC; Shahla BK; Kulek A; Qi JL; Wang XM; Ling LJ; Yang YH
    Chem Biol Drug Des; 2014 Nov; 84(5):603-15. PubMed ID: 24797889
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
    Zúñiga MA; Alderete JB; Jaña GA; Jiménez VA
    J Comput Aided Mol Des; 2017 Jul; 31(7):643-652. PubMed ID: 28597356
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures.
    Li W; Sun H; Xu S; Zhu Z; Xu J
    Future Med Chem; 2017 Oct; 9(15):1765-1794. PubMed ID: 28929799
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Selective expression of beta tubulin isotypes in gerbil vestibular sensory epithelia and neurons.
    Perry B; Jensen-Smith HC; Ludueña RF; Hallworth R
    J Assoc Res Otolaryngol; 2003 Sep; 4(3):329-38. PubMed ID: 14690051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design, Synthesis, and Biological Evaluation of Chalcone-Containing Shikonin Derivatives as Inhibitors of Tubulin Polymerization.
    Qiu HY; Wang F; Wang X; Sun WX; Qi JL; Pang YJ; Yang RW; Lu GH; Wang XM; Yang YH
    ChemMedChem; 2017 Mar; 12(5):399-406. PubMed ID: 28211616
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A label-free mass spectrometry method for relative quantitation of β-tubulin isotype expression in human tumor tissue.
    Miller LM; Huang Yang CP; Xiao H; Isaac S; Sève P; Dumontet C; Band Horwitz S; Hogue Angeletti R
    Proteomics Clin Appl; 2012 Oct; 6(9-10):502-6. PubMed ID: 22996942
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elucidating the mechanism of action of the clinically approved taxanes: a comprehensive comparison of local and allosteric effects.
    Churchill CD; Klobukowski M; Tuszynski JA
    Chem Biol Drug Des; 2015 Nov; 86(5):1253-66. PubMed ID: 26032329
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The high-resolution X-ray structure of vinca-domain inhibitors of microtubules provides a rational approach for drug design.
    Chengyong W; Jinghong X; Yanyan W; Qing-Jie X; Lingling M; Yuyan L; Hai C; Qian L; Quan Z; Bo S; Yuxi W
    FEBS Lett; 2021 Jan; 595(2):195-205. PubMed ID: 33220079
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells.
    St George M; Ayoub AT; Banerjee A; Churchill CD; Winter P; Klobukowski M; Cass CE; Ludueña RF; Tuszynski JA; Damaraju S
    PLoS One; 2015; 10(6):e0129168. PubMed ID: 26052950
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of a novel class of tubulin inhibitors with promising anticancer activities.
    Xi J; Zhu X; Feng Y; Huang N; Luo G; Mao Y; Han X; Tian W; Wang G; Han X; Luo R; Huang Z; An J
    Mol Cancer Res; 2013 Aug; 11(8):856-64. PubMed ID: 23666368
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of key interactions of benzimidazole resistance-associated amino acid mutations in Ascaris β-tubulins by molecular docking simulations.
    Jones BP; van Vliet AHM; LaCourse EJ; Betson M
    Sci Rep; 2022 Aug; 12(1):13725. PubMed ID: 35961997
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Discovery of novel tubulin inhibitors via structure-based hierarchical virtual screening.
    Cao R; Liu M; Yin M; Liu Q; Wang Y; Huang N
    J Chem Inf Model; 2012 Oct; 52(10):2730-40. PubMed ID: 22992059
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Design, synthesis and biological evaluation of millepachine derivatives as a new class of tubulin polymerization inhibitors.
    Wang G; Peng F; Cao D; Yang Z; Han X; Liu J; Wu W; He L; Ma L; Chen J; Sang Y; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2013 Nov; 21(21):6844-54. PubMed ID: 23993668
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and anticancer activity of analogues of phenstatin, with a phenothiazine A-ring, as a new class of microtubule-targeting agents.
    Abuhaie CM; Bîcu E; Rigo B; Gautret P; Belei D; Farce A; Dubois J; Ghinet A
    Bioorg Med Chem Lett; 2013 Jan; 23(1):147-52. PubMed ID: 23200248
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Homology modelling, molecular dynamics simulation and docking evaluation of β-tubulin of Schistosoma mansoni.
    El-Shehabi F; Mansour B; Bayoumi WA; El Bialy SA; Elmorsy MA; Eisa HM; Taman A
    Biophys Chem; 2021 Nov; 278():106660. PubMed ID: 34482215
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expanding the Structural Diversity of Tubulin-Targeting Agents: Development of Highly Potent Benzimidazoles for Treating Fungal Diseases.
    Yang S; Zhang JR; Li M; Feng YM; Yang LL; Long ZQ; Zhou X; Wu ZB; Liu LW; Yang S
    J Agric Food Chem; 2024 Jul; 72(28):15541-15551. PubMed ID: 38959381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Experimental and computational study of the interaction of novel colchicinoids with a recombinant human αI/βI-tubulin heterodimer.
    Mane JY; Semenchenko V; Perez-Pineiro R; Winter P; Wishart D; Tuszynski JA
    Chem Biol Drug Des; 2013 Jul; 82(1):60-70. PubMed ID: 23480279
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Application of GA-MLR for QSAR Modeling of the Arylthioindole Class of Tubulin Polymerization Inhibitors as Anticancer Agents.
    Ahmadi S; Habibpour E
    Anticancer Agents Med Chem; 2017; 17(4):552-565. PubMed ID: 27528182
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Structure of 4'-demethylepipodophyllotoxin in complex with tubulin provides a rationale for drug design.
    Niu L; Wang Y; Wang C; Wang Y; Jiang X; Ma L; Wu C; Yu Y; Chen Q
    Biochem Biophys Res Commun; 2017 Nov; 493(1):718-722. PubMed ID: 28864414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.